Iron-induced Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Iron-induced Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2012-02-09Clinical Trial Update: Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Deferiprone has received approval for marketing to treat iron overload in patients with thalassemia and iron-induced heart disease.